Cargando…
Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews
BACKGROUND: Pressures on health care budgets have led policy makers to discuss how to balance the provision of costly technologies to populations in need and making coverage decisions under uncertainty. Coverage with evidence development (CED) is being employed to meet these challenges. METHODS: Twe...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599546/ https://www.ncbi.nlm.nih.gov/pubmed/23497271 http://dx.doi.org/10.1186/1472-6963-13-88 |
_version_ | 1782262987735695360 |
---|---|
author | Bishop, Danielle Lexchin, Joel |
author_facet | Bishop, Danielle Lexchin, Joel |
author_sort | Bishop, Danielle |
collection | PubMed |
description | BACKGROUND: Pressures on health care budgets have led policy makers to discuss how to balance the provision of costly technologies to populations in need and making coverage decisions under uncertainty. Coverage with evidence development (CED) is being employed to meet these challenges. METHODS: Twenty-four interviews were carried out between June 2009 and December 2010 with researchers, decision makers and policy makers from Australia, Canada, United Kingdom and United States. Three phases of coding occurred, the first being manual coding where the interviews were read and notes were taken and nodes were extracted and imputed. NVIVO coding was applied to the interview transcripts, with both broad general searches for word usages and imputed nodes. RESULTS: Four overarching thematic areas emerged out of contextual analysis of the interviews – (1) what constitutes CED; (2) the lack of a systematic approach/governance structure; (3) the role of the pharmaceutical industry and overt political considerations in CED; and (4) alternatives and barriers to CED. We explore these themes and then use concrete examples of CED projects in each of the four countries to illustrate the political issues that our interviewees raised. CONCLUSION: Until the underlying political nature of CED is recognized then fundamental questions about its usefulness and operation will remain unresolved. |
format | Online Article Text |
id | pubmed-3599546 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35995462013-03-17 Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews Bishop, Danielle Lexchin, Joel BMC Health Serv Res Research Article BACKGROUND: Pressures on health care budgets have led policy makers to discuss how to balance the provision of costly technologies to populations in need and making coverage decisions under uncertainty. Coverage with evidence development (CED) is being employed to meet these challenges. METHODS: Twenty-four interviews were carried out between June 2009 and December 2010 with researchers, decision makers and policy makers from Australia, Canada, United Kingdom and United States. Three phases of coding occurred, the first being manual coding where the interviews were read and notes were taken and nodes were extracted and imputed. NVIVO coding was applied to the interview transcripts, with both broad general searches for word usages and imputed nodes. RESULTS: Four overarching thematic areas emerged out of contextual analysis of the interviews – (1) what constitutes CED; (2) the lack of a systematic approach/governance structure; (3) the role of the pharmaceutical industry and overt political considerations in CED; and (4) alternatives and barriers to CED. We explore these themes and then use concrete examples of CED projects in each of the four countries to illustrate the political issues that our interviewees raised. CONCLUSION: Until the underlying political nature of CED is recognized then fundamental questions about its usefulness and operation will remain unresolved. BioMed Central 2013-03-09 /pmc/articles/PMC3599546/ /pubmed/23497271 http://dx.doi.org/10.1186/1472-6963-13-88 Text en Copyright ©2013 Bishop and Lexchin; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bishop, Danielle Lexchin, Joel Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews |
title | Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews |
title_full | Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews |
title_fullStr | Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews |
title_full_unstemmed | Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews |
title_short | Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews |
title_sort | politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599546/ https://www.ncbi.nlm.nih.gov/pubmed/23497271 http://dx.doi.org/10.1186/1472-6963-13-88 |
work_keys_str_mv | AT bishopdanielle politicsanditsintersectionwithcoveragewithevidencedevelopmentaqualitativeanalysisfromexpertinterviews AT lexchinjoel politicsanditsintersectionwithcoveragewithevidencedevelopmentaqualitativeanalysisfromexpertinterviews |